By Kathleen J. Sullivan

School of Medicine Dean Lloyd Minor speaking to the Faculty Senate.

In his first presentation to Stanford's Faculty Senate, Dr. Lloyd B. Minor, dean of the School of Medicine, said the goal of the Campaign for Stanford Medicine is to "lead the biomedical revolution" by promoting fundamental, clinical and translational discovery, by transforming patient care and by training future leaders.

"We are the epicenter of innovation," Minor said in a Thursday presentation. Minor became dean of the Medical School in December 2012.

"We are drawn to the difficult problems, not the problems that can be solved with incremental solutions or approaches, but the problems that no one else tackles. The problems that, at first, we don't even know how to conceptualize and approach to solve them. And we develop the platforms and the paradigms that change the future."

As an example, Minor cited the work of Stanford Professor Karl Deisseroth, a professor of bioengineering and of psychiatry and behavioral sciences, who led the multidisciplinary team that combined neuroscience and chemical engineering and developed a process that renders a mouse brain transparent.

Under the Campaign for Stanford Medicine, which President John Hennessy launched last May, Stanford is building a new hospital on the Palo Alto site.

During his 15-minute presentation using many facts and figures, Minor provided an overview of the Stanford School of Medicine.

Currently, the Medical School has 411 students studying to become doctors, 937 residents and clinical fellows being trained in Stanford hospitals by faculty, 713 PhD candidates and 1,277 postdoctoral research scholars.

Emphasizing the excellence of the school's faculty, Minor noted that its ranks include six living Nobel Laureates.

Read the original here:

Stanford Medical School dean shares vision for leading biomedical revolution